Hepatic arterial infusion chemotherapy and immune checkpoint inhibitors, alone or in combination, in advanced hepatocellular carcinoma with macrovascular invasion: a single-centre experience in Taiwan.

Juei-Seng Wu, Tzu-Chun Hong,Hung-Tsung Wu,Yih-Jyh Lin,Ting-Tsung Chang,Chung-Teng Wang,Wen-Chun Liu,Ming-Tsung Hsieh,I-Chin Wu,Po-Jun Chen,Chiung-Yu Chen,Sheng-Hsiang Lin,Chiao-Hsiung Chuang,Meng-Zhi Han,Huang-Pin Chen,Hong-Ming Tsai,Hsin-Yu Kuo

Journal of gastrointestinal oncology（2023）

引用 0|浏览1

暂无评分

摘要

HAIC combined with ICIs had a superior response of PVTT compared to HAIC alone, and was associated with reduced risk of progression or death. Future studies are needed to address the survival benefit of the combination therapy in advanced HCC with MVI.

查看译文

关键词

hepatic arterial infusion chemotherapy (HAIC),hepatocellular carcinoma (HCC),immune checkpoint inhibitor (ICI)

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要